| Code | CSB-MP023978HU2 |
| Abbreviation | Recombinant Human TNFRSF1B protein, partial (Active) |
| MSDS | |
| Size | $116 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
TNFRSF1B (TNF-R2/p75) mediates critical TNF-α signaling in immune regulation and tumor microenvironment modulation, making it a key target in oncology drug discovery. This recombinant human TNFR2 construct spans the extracellular ligand-binding domain (aa 23–257) with a C-terminal hFc1 tag, and its functional integrity is confirmed by ELISA binding to immobilized TNF-α with an EC50 of 1.162–1.481 ng/ml, supporting use in ligand-receptor interaction assays, competitive inhibition studies, and blocking antibody screening. Mammalian cell expression preserves native glycosylation and disulfide-dependent folding essential for conformationally accurate epitope mapping and affinity characterization by SPR or BLI. Purity exceeding 95% by SDS-PAGE combined with endotoxin levels below 1.0 EU/μg satisfies the criteria typical for therapeutic antibody validation and small-molecule inhibitor screening in cancer-focused programs.
Applications : Antigen
Review: We validated the binding activity of human TNFRSF1B and ligand human TNFRSF1B through functional ELISA, and the results showed good binding activity, which is basically consistent with the data on the website. It was subsequently used as an antigen to immunize mouse, the titer was high, and ideal positive clones were screened through ELISA screening!
By Anonymous